ALLR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Allarity Therapeutics Inc (ALLR) is not a strong buy for a beginner, long-term investor at this time. The stock lacks positive momentum, has weak financial performance, and no significant catalysts or trading signals to justify immediate investment.
The MACD is positive and expanding, indicating slight bullish momentum. RSI is neutral at 62.768, and moving averages are converging, showing no clear trend. The stock is trading near its pivot level of 1.202 with resistance at 1.267 and support at 1.137.
NULL identified. No recent news or significant insider/hedge fund activity. Technical indicators show slight bullish momentum but no strong trend.
Weak financial performance in Q4 2025 with a significant drop in net income (-54.74% YoY) and EPS (-87.79% YoY). No recent news or trading signals to indicate a positive shift.
In Q4 2025, revenue remained flat at $320,000 (0.00% YoY), net income dropped significantly to -$3,373,000 (-54.74% YoY), and EPS fell to -0.21 (-87.79% YoY). Gross margin remained stable at 100%.
No data on analyst ratings or price target changes.
